A gynecologist looking at a patient's mammogram at the hospital getty

Over the next 12 months, tens of thousands of women across the U.S. will begin to have their short-term risk of breast cancer assessed in a new way. For the first time, they will receive risk scores revealing their likelihood of developing the disease in the next five years, not based on their genetics or family history, but through features on their mammogram, visible only to an AI tool called Clairity Breast.

This new tool was authorized by the Food and Drug Administration in May this year, a move that represented a seismic breakthrough for intelligent predictive algorithms. As noted by the Wall Street Journal , Clairity’s model, which has been trained on 400,000 routine mammograms, detects signs which are “so

See Full Page